HER2 negative breast cancer – Life with Disease

Go back

HER2 negative breast cancer is the most common form of breast cancer, accounting for about 80% of all diagnosed cases. This type occurs when cancer cells in the breast do not produce high levels of a protein called HER2, which normally helps control cell growth and repair. Understanding this diagnosis and its implications can help patients and their families navigate treatment decisions and plan for the future with greater confidence.

Understanding Your Outlook with HER2 Negative Breast Cancer

Learning that you have HER2 negative breast cancer can feel overwhelming, but it’s important to know that this diagnosis often comes with a more hopeful outlook compared to HER2 positive cancers. The prognosis for HER2 negative breast cancer varies significantly depending on several factors that your healthcare team will carefully evaluate.[2]

When doctors talk about prognosis, they’re referring to the likely course and outcome of your disease. For HER2 negative breast cancer, the outlook depends largely on whether your cancer is also positive for hormone receptors like estrogen or progesterone. About 70% of HER2 negative breast cancers are hormone receptor positive, meaning they grow in response to these hormones. These cancers tend to respond well to hormone-blocking treatments and generally have a favorable outlook.[1]

The remaining 11% of HER2 negative cases are triple negative, meaning they lack HER2 proteins and both hormone receptors. Triple negative breast cancer is typically more aggressive and requires different treatment approaches. However, advances in medical research continue to improve outcomes for all types of HER2 negative breast cancer.[1]

Your stage at diagnosis plays a critical role in determining your prognosis. When breast cancer is caught early, before it has spread beyond the breast or nearby lymph nodes, survival rates are significantly higher. This is why regular screening and early detection remain so important. Your doctor will also consider factors like the size of your tumor, whether cancer cells have reached your lymph nodes, how fast the cancer cells are growing, and your overall health when discussing your individual outlook.[2]

⚠️ Important
HER2 negative breast cancer tends to be less aggressive than HER2 positive cancer because it doesn’t have the excess HER2 protein that can drive rapid tumor growth. This generally means a better overall outlook, though each person’s cancer is unique and requires individualized care and treatment planning.

How the Disease Progresses Without Treatment

Understanding what happens if HER2 negative breast cancer goes untreated is important for appreciating why early intervention matters. Without treatment, cancer cells that begin in the breast tissue continue to divide and multiply, forming larger tumors over time.[1]

In the early stages, a small cluster of abnormal cells may remain confined to the milk ducts or lobules of the breast. As time passes without intervention, these cells can break through the walls of these structures and invade surrounding breast tissue. This transition from noninvasive to invasive cancer marks a significant change in how the disease behaves and spreads.

As the tumor grows larger, cancer cells can enter nearby lymph nodes, particularly those in the armpit area. The lymphatic system acts like a highway network throughout your body, and once cancer cells gain access to this system, they can travel to distant organs. Common sites where breast cancer spreads include the bones, liver, lungs, and brain.[18]

The speed at which HER2 negative breast cancer progresses varies from person to person. Hormone receptor positive, HER2 negative cancers often grow more slowly than triple negative types. However, even slow-growing cancers will eventually advance without treatment, which is why doctors emphasize the importance of not delaying care once a diagnosis is made.

Possible Complications and Challenges

HER2 negative breast cancer can lead to various complications, both from the disease itself and sometimes from its treatment. Understanding these potential challenges helps you and your healthcare team watch for warning signs and address problems early.

When cancer spreads to the lymph nodes in your armpit, it can disrupt the normal flow of lymph fluid. This can lead to a condition called lymphedema, where your arm, hand, or chest area swells because fluid builds up in the tissues. Lymphedema can develop during or even years after treatment, particularly if lymph nodes are removed during surgery or damaged by radiation therapy. The swelling can be uncomfortable and may limit your range of motion.[4]

If breast cancer spreads to other parts of your body, it becomes what doctors call metastatic breast cancer. This is the most serious complication because cancer in distant organs is much harder to eliminate completely. When breast cancer spreads to the bones, it can cause pain, fractures, and elevated calcium levels in your blood. Cancer in the liver can affect how your body processes nutrients and medications. Lung metastases may cause breathing difficulties and persistent coughing. Brain metastases can lead to headaches, seizures, or changes in mental function.[18]

Some patients develop side effects from their cancer treatments that become complications in their own right. Chemotherapy can weaken your immune system, making you more vulnerable to infections. Hormone therapy may trigger menopausal symptoms like hot flashes, mood changes, and bone thinning. Radiation can cause skin changes and fatigue. Surgery carries risks of infection, bleeding, and complications from anesthesia.

Cancer and its treatment can also affect your heart health, a complication that may not appear until months or years later. Some chemotherapy drugs can damage heart muscle, and radiation to the left breast may affect the nearby heart tissue. Your medical team will monitor your heart function if you receive treatments known to carry these risks.

Impact on Your Daily Life and Well-Being

Living with HER2 negative breast cancer affects far more than just your physical health. The disease and its treatment can reshape nearly every aspect of your daily routine, relationships, and sense of self.

Physically, you may experience fatigue that goes beyond normal tiredness. This cancer-related exhaustion can make even simple tasks feel overwhelming. You might need to rest more frequently throughout the day and may find that you cannot maintain the same activity level you once did. Treatment side effects like nausea, pain, or hot flashes from hormone therapy can interrupt sleep and make it harder to focus on work or hobbies.[17]

Your work life may require adjustments. Some people continue working throughout treatment, while others need to reduce their hours or take medical leave. This depends on the type of work you do, the intensity of your treatment schedule, and how your body responds. Frequent medical appointments for chemotherapy, radiation, or check-ups can make maintaining a regular work schedule challenging. You may need to have honest conversations with your employer about flexibility and accommodations.

Emotionally, a breast cancer diagnosis can trigger anxiety, fear, sadness, and uncertainty about the future. You might worry about your prognosis, how treatment will affect you, or the financial burden of cancer care. These feelings are completely normal and valid. Many patients find that their emotional state fluctuates throughout their cancer journey, with some days feeling more hopeful than others.[17]

Your relationships with family and friends may shift as well. Some people become closer to loved ones during this time, while others feel isolated or misunderstood. Partners may struggle with their own fears about your illness while trying to provide support. Children, depending on their age, may have difficulty understanding what’s happening and why a parent is sick. Open communication about your needs and feelings can help maintain strong connections during this difficult period.

Body image concerns often arise, especially if treatment involves surgery that changes the appearance of your breasts. Whether you have a lumpectomy that removes part of the breast or a mastectomy that removes the entire breast, adjusting to physical changes takes time. Hair loss from chemotherapy can also affect how you see yourself. These changes can impact your self-esteem and intimate relationships.

⚠️ Important
Self-care during cancer treatment extends beyond managing physical symptoms. Taking time for activities that bring you joy, connecting with support groups, asking for help when you need it, and addressing your emotional health through therapy or counseling are all important parts of living well with HER2 negative breast cancer. Don’t hesitate to tell your healthcare team about any challenges you’re facing in daily life.

Financial stress is another reality for many cancer patients. Medical bills, insurance co-pays, prescription costs, and lost income from missed work can create significant financial strain. Some people must also pay for transportation to treatment centers, childcare, or home help during recovery periods. Financial concerns add another layer of stress to an already challenging situation.

Despite these challenges, many patients find ways to adapt and maintain quality of life. Breaking tasks into smaller, manageable pieces can help when energy is low. Accepting help from others, whether with household chores, meal preparation, or childcare, can ease your burden. Finding new ways to enjoy hobbies, even if you must modify them, helps maintain a sense of normalcy. Connecting with other cancer patients who understand what you’re going through can provide valuable emotional support and practical advice.[19]

Supporting Your Family Through Clinical Trials

When you have HER2 negative breast cancer, you and your family might hear about clinical trials as a treatment option. Understanding what these trials involve and how your loved ones can support you through this process is valuable knowledge to have.

Clinical trials are research studies that test new treatments or new ways of using existing treatments. For HER2 negative breast cancer, these trials might study new chemotherapy drugs, innovative hormone therapies, immunotherapy approaches, or novel targeted treatments. Some trials compare standard treatments with new options to see which works better.[4]

Your family should know that participating in a clinical trial is always voluntary. You have the right to join or decline, and you can withdraw from a trial at any time without affecting your regular care. Trials have strict rules about who can participate, based on factors like your cancer type, stage, previous treatments, and overall health. Not everyone who wants to join a trial will qualify.

Family members can help by attending appointments with you when clinical trials are discussed. Having another person there to listen, ask questions, and take notes is extremely helpful because medical information can be overwhelming. Your loved ones can help you understand the potential benefits and risks of trial participation, compare the trial option with standard treatment, and think through how the trial requirements might affect your daily life.

If you decide to join a clinical trial, your family can provide practical support in several ways. They can help keep track of your appointment schedule, which may be more frequent in a trial than with standard treatment. They can watch for and report any side effects or changes in your condition. They can assist with transportation to the trial center, which might be farther from home than your regular cancer center.

Emotional support is equally important. Your family can remind you why you chose to participate in the trial when things get difficult. They can celebrate the contribution you’re making to medical research that may help future patients. They can be there to listen when you need to talk about your experiences or concerns.

Finding clinical trials requires some research. Your oncologist may know about trials that match your situation, but you can also search online databases of active trials. Your family can help with this research, looking for trials in your area or even in other locations if you’re willing and able to travel. They can contact trial coordinators to ask preliminary questions and gather information packets.

Your relatives should understand that being in a clinical trial doesn’t mean giving up standard care. Many trials compare a new treatment added to standard therapy versus standard therapy alone. Others test whether a new drug works as well as the standard treatment but with fewer side effects. The trial protocol will clearly explain what treatments you’ll receive.

Family members should also know about your rights as a trial participant. You must give informed consent, meaning the research team fully explains the study before you agree to join. You can ask as many questions as you need. You’ll receive regular monitoring and care throughout the trial. If the trial treatment causes serious side effects, you can stop participating. All of this information should be clearly explained in the consent documents.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Anastrozole (Arimidex) – An aromatase inhibitor that lowers estrogen levels to slow the growth of hormone receptor positive breast cancer
  • Exemestane (Aromasin) – An aromatase inhibitor used to reduce estrogen production in hormone receptor positive breast cancer
  • Letrozole (Femara) – An aromatase inhibitor that blocks estrogen production to treat hormone receptor positive breast cancer
  • Fulvestrant (Faslodex) – A hormone therapy that blocks estrogen from connecting to cancer cells
  • Tamoxifen (Nolvadex, Soltamox) – A hormone therapy that prevents estrogen from binding to cancer cells
  • Toremifene (Fareston) – A hormone therapy medication that blocks estrogen receptors
  • Goserelin (Zoladex) – A medication that stops the body from making estrogen
  • Leuprolide (Lupron) – A drug that reduces estrogen production in the body
  • Olaparib (Lynparza) – A PARP inhibitor that prevents cancer cells from repairing themselves, used for patients with BRCA gene mutations
  • Talazoparib (Talzenna) – A PARP inhibitor that stops cancer cell repair in patients with BRCA mutations
  • Capivasertib (Truqap) – A targeted therapy that blocks AKT proteins involved in cancer cell growth

Ongoing Clinical Trials on HER2 negative breast cancer

  • Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Preoperative Treatment for HER2-Negative Breast Cancer Using Pembrolizumab, Paclitaxel, and Carboplatin in Patients Not Responding to Initial Chemotherapy

    Recruiting

    1 1 1
    Investigated diseases:
    Poland
  • Study on Everolimus and Exemestane for Patients with Metastatic Breast Cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary
  • Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1
    Investigated drugs:
    Spain
  • Study of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria France Hungary Italy Spain
  • Study of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases

    Not recruiting

    1 1
    Investigated drugs:
    Austria Spain
  • Study on Olaparib for Patients with Advanced HER2-Negative Breast Cancer and Specific Genetic Mutations

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Effect of Tamoxifen and Chemotherapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with Low Recurrence Scores

    Not recruiting

    1 1 1 1
    Spain
  • Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

References

https://my.clevelandclinic.org/health/diseases/her2-negative-breast-cancer

https://www.webmd.com/breast-cancer/breast-cancer-her2-negative

https://www.medicalnewstoday.com/articles/326099

https://www.upmc.com/services/breast/conditions/her2-negative-breast-cancer

https://webmd.com/breast-cancer/breast-cancer-her2-negative

https://www.bcrf.org/about-breast-cancer/her2-status-breast-cancer/

https://www.everydayhealth.com/breast-cancer/her2-negative-breast-cancer/guide/

https://www.facingourrisk.org/info/risk-management-and-treatment/cancer-treatment/by-cancer-type/breast/stages-and-subtypes

https://www.healthline.com/health/breast-cancer/her2-positive-vs-her2-negative

https://my.clevelandclinic.org/health/diseases/her2-negative-breast-cancer

https://www.webmd.com/breast-cancer/her2-neg-metastatic-treatment

https://www.healthline.com/health/breast-cancer/her2-negative-breast-cancer-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC8931202/

https://www.facingourrisk.org/XRAY/treatment-for-HER2-low-metastatic-breast-cancer

https://www.upmc.com/services/breast/conditions/her2-negative-breast-cancer

https://my.clevelandclinic.org/health/diseases/her2-negative-breast-cancer

https://health.clevelandclinic.org/self-care-her2-negative-metastatic-breast-cancer

https://www.nationalbreastcancer.org/breast-cancer-stage-4/

https://www.everydayhealth.com/breast-cancer/self-care/

https://www.webmd.com/breast-cancer/her2-neg-metastatic-treatment

https://tnbcfoundation.org/

https://www.healthline.com/health/breast-cancer/her2-negative

https://www.mdanderson.org/cancerwise/triple-negative-breast-cancer-5-things-you-should-know.h00-158986656.html

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What does it mean when my breast cancer is HER2 negative?

HER2 negative means your cancer cells don’t have high levels of the HER2 protein on their surface. HER2 is a protein that normally helps control cell growth, but when present in excess, it can make cancer grow faster. Since your cancer is HER2 negative, treatments that specifically target HER2 won’t work for you, but you’ll have other effective treatment options based on whether your cancer has hormone receptors.

Is HER2 negative breast cancer better or worse than HER2 positive?

HER2 negative breast cancer generally has a better outlook than HER2 positive because it tends to be less aggressive. The excess HER2 protein in HER2 positive cancers drives faster tumor growth, making those cancers more likely to multiply and spread quickly. However, your individual prognosis depends on many factors beyond HER2 status, including your cancer’s stage, grade, hormone receptor status, and how well it responds to treatment.

What treatments are available for HER2 negative breast cancer?

Treatment options depend on whether your HER2 negative cancer is also hormone receptor positive or triple negative. If your cancer has hormone receptors, you may receive hormone therapy drugs like tamoxifen or aromatase inhibitors. Other treatments include surgery (lumpectomy or mastectomy), chemotherapy, radiation therapy, and in some cases, targeted therapies like PARP inhibitors for patients with BRCA gene mutations. Your doctor will recommend a treatment plan based on your specific cancer characteristics.

Can my HER2 status change over time?

Yes, cancers can change their characteristics over time. If your cancer returns after initial treatment or spreads to other parts of your body, your doctor may test it again to see if the HER2 status has changed. This is why repeat biopsies are sometimes necessary, as knowing the current status of your cancer helps guide the most appropriate treatment choices.

What is the difference between HR positive/HER2 negative and triple negative breast cancer?

Both are types of HER2 negative breast cancer, but they differ in hormone receptor status. HR positive/HER2 negative cancers have receptors for estrogen or progesterone and grow in response to these hormones – this accounts for about 70% of all breast cancers. Triple negative breast cancer lacks HER2, estrogen receptors, and progesterone receptors, making up about 11% of cases. Triple negative cancers are typically more aggressive and require different treatment approaches than hormone receptor positive cancers.

🎯 Key takeaways

  • HER2 negative breast cancer accounts for about 80% of all breast cancer cases and is generally less aggressive than HER2 positive types
  • Your HER2 status must be determined through laboratory testing of tumor tissue and cannot be identified through physical examination alone
  • Most HER2 negative breast cancers (70%) are also hormone receptor positive, meaning they respond to hormone-blocking treatments
  • Triple negative breast cancer, which lacks HER2 and both hormone receptors, requires different treatment approaches and tends to be more aggressive
  • Treatment options for HER2 negative breast cancer include surgery, chemotherapy, radiation, hormone therapy, and targeted therapies depending on your specific cancer characteristics
  • Living with HER2 negative breast cancer affects physical health, emotional well-being, relationships, work life, and daily routines in ways that extend beyond medical treatment
  • Family members can provide crucial support by attending appointments, helping with research about treatment options including clinical trials, and offering emotional encouragement
  • Self-care during treatment includes managing physical symptoms, addressing emotional health, maintaining social connections, and finding ways to continue activities that bring joy